Cargando…
Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system
Bispecific antibodies have emerged in recent years as a promising field of research for therapies in oncology, inflammable diseases, and infectious diseases. Their capability of dual target recognition allows for novel therapeutic hypothesis to be tested, where traditional mono-specific antibodies w...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623329/ https://www.ncbi.nlm.nih.gov/pubmed/25427258 http://dx.doi.org/10.4161/19420862.2015.989013 |
_version_ | 1782397668920655872 |
---|---|
author | Xu, Yiren Lee, John Tran, Cuong Heibeck, Tyler H Wang, Willie D Yang, Junhao Stafford, Ryan L Steiner, Alexander R Sato, Aaron K Hallam, Trevor J Yin, Gang |
author_facet | Xu, Yiren Lee, John Tran, Cuong Heibeck, Tyler H Wang, Willie D Yang, Junhao Stafford, Ryan L Steiner, Alexander R Sato, Aaron K Hallam, Trevor J Yin, Gang |
author_sort | Xu, Yiren |
collection | PubMed |
description | Bispecific antibodies have emerged in recent years as a promising field of research for therapies in oncology, inflammable diseases, and infectious diseases. Their capability of dual target recognition allows for novel therapeutic hypothesis to be tested, where traditional mono-specific antibodies would lack the needed mode of target engagement. Among extremely diverse architectures of bispecific antibodies, knobs-into-holes (KIHs) technology, which involves engineering C(H)3 domains to create either a “knob” or a “hole” in each heavy chain to promote heterodimerization, has been widely applied. Here, we describe the use of a cell-free expression system (Xpress CF) to produce KIH bispecific antibodies in multiple scaffolds, including 2-armed heterodimeric scFv-KIH and one-armed asymmetric BiTE-KIH with tandem scFv. Efficient KIH production can be achieved by manipulating the plasmid ratio between knob and hole, and further improved by addition of prefabricated knob or hole. These studies demonstrate the versatility of Xpress CF in KIH production and provide valuable insights into KIH construct design for better assembly and expression titer. |
format | Online Article Text |
id | pubmed-4623329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-46233292015-11-26 Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system Xu, Yiren Lee, John Tran, Cuong Heibeck, Tyler H Wang, Willie D Yang, Junhao Stafford, Ryan L Steiner, Alexander R Sato, Aaron K Hallam, Trevor J Yin, Gang MAbs Reports Bispecific antibodies have emerged in recent years as a promising field of research for therapies in oncology, inflammable diseases, and infectious diseases. Their capability of dual target recognition allows for novel therapeutic hypothesis to be tested, where traditional mono-specific antibodies would lack the needed mode of target engagement. Among extremely diverse architectures of bispecific antibodies, knobs-into-holes (KIHs) technology, which involves engineering C(H)3 domains to create either a “knob” or a “hole” in each heavy chain to promote heterodimerization, has been widely applied. Here, we describe the use of a cell-free expression system (Xpress CF) to produce KIH bispecific antibodies in multiple scaffolds, including 2-armed heterodimeric scFv-KIH and one-armed asymmetric BiTE-KIH with tandem scFv. Efficient KIH production can be achieved by manipulating the plasmid ratio between knob and hole, and further improved by addition of prefabricated knob or hole. These studies demonstrate the versatility of Xpress CF in KIH production and provide valuable insights into KIH construct design for better assembly and expression titer. Taylor & Francis 2014-11-26 /pmc/articles/PMC4623329/ /pubmed/25427258 http://dx.doi.org/10.4161/19420862.2015.989013 Text en © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. |
spellingShingle | Reports Xu, Yiren Lee, John Tran, Cuong Heibeck, Tyler H Wang, Willie D Yang, Junhao Stafford, Ryan L Steiner, Alexander R Sato, Aaron K Hallam, Trevor J Yin, Gang Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system |
title | Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system |
title_full | Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system |
title_fullStr | Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system |
title_full_unstemmed | Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system |
title_short | Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system |
title_sort | production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system |
topic | Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623329/ https://www.ncbi.nlm.nih.gov/pubmed/25427258 http://dx.doi.org/10.4161/19420862.2015.989013 |
work_keys_str_mv | AT xuyiren productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem AT leejohn productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem AT trancuong productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem AT heibecktylerh productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem AT wangwillied productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem AT yangjunhao productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem AT staffordryanl productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem AT steineralexanderr productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem AT satoaaronk productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem AT hallamtrevorj productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem AT yingang productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem |